Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype

Breast Cancer Research

Volumn 5, Issue 3, 2003, Pages

  Nunez Villar M J ^a   Martinez Arribas F ^a   Pollan M ^b   Lucas, A R ^a   Sanchez J ^a,c   Tejerina, A ^a   Schneider, J ^a,d  

^a Centro de Patología de la Mama Fundación Tejerina   (Spain)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Breast; Cancer; Mammaglobin; Reverse transcriptase polymerase chain reaction

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; MAMMAGLOBIN; PROGESTERONE RECEPTOR; PROTEIN P53; TUMOR PROTEIN; UTEROGLOBIN;

ARTICLE; BREAST CANCER; CANCER GRADING; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DIPLOIDY; DISEASE ASSOCIATION; DNA CONTENT; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MASTECTOMY; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADENOCARCINOMA; BIOSYNTHESIS; BREAST TUMOR; GENE EXPRESSION REGULATION; GENETICS; LUNG CARCINOMA; LYMPH NODE; METASTASIS; METHODOLOGY; PAGET NIPPLE DISEASE; PATHOLOGY; PHENOTYPE; PHYSIOLOGY;

ADENOCARCINOMA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DIPLOIDY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PHENOTYPE; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTEROGLOBIN;

EID: 1542324603     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr587     Document Type: Article

References (11)

1. Watson M, Darrow C, Zimonjic D, Popescu N, Fleming T: Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13. Oncogene. 1994, 16: 817-824. 10.1038/sj.onc.1201597.
2. Ni J, Kalff-Suske M, Gentz R, Schageman J, Beato M, Klug J: All human genes of the uteroglobin family are localized on chromosome 11q12.2 and form a dense cluster. Ann N Y Acad Sci. 2000, 923: 25-42.
3. Watson M, Fleming T: Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 1996, 56: 860-865.
4. Zach O, Kasparu H, Krieger O, Hehenwarter W, Girschikowski M, Lutz D: Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol. 1999, 17: 2015-2019.
5. Grünewald K, Haun M, Fiegl M, Urbanek M, Müller-Holzner E, Massoner A, Riha K, Propst A, Marth C, Gastl G: Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction. Lab Invest. 2002, 82: 1147-1153.
6. Grünewald K, Haun M, Urbanek M, Fiegl M, Müller-Holzner E, Gunsilius E, Dünser M, Marth C, Gastl G: Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab Invest. 2000, 80: 1071-1077.
7. Kataoka A, Mori M, Sadanaga N, Ueo H, Tsuji K, Rai Y, Barnard GF, Sugimachi K: RT-PCR detection of breast cancer cells in sentinel lymph modes. Int J Oncol. 2000, 16: 1147-1152.
8. Colpitts TL, Billing-Medel P, Friedman P, Granados EN, Hayden M, Hodges S, Menhart N, Roberts L, Russell J, Stroupe SD: Mammaglobin is found in breast tissue as a complex with BU101. Biochemistry. 2001, 40: 11048-11059. 10.1021/bi010284f.
9. Schneider J, Pollán M, Jiménez E, Ruibal A, Lucas AR, Núñez MI, Sánchez J, Tejerina A: Histologic grade, Ki67 and CD44 are predictors of axillary lymph node invasion in early (T1) breast cancer. Tumour Biol. 1999, 20: 319-330. 10.1159/000030096.
10. Schneider J, Rubio MP, Rodríguez-Escudero FJ, Seizinger BS, Castresana JS: Identification of p53 mutations by means of SSCP (single strand conformation polymorphism) analysis in gynaecologic tumors: comparison with the results of immunohistochemistry. Eur J Cancer. 1994, 30A: 504-508.
11. Schmitt FC, Soares R, Cirnes L, Seruca R: p53 in breast carcinomas: association between presence of mutation and immunohistochemical expression using a semiquantitative approach. Pathol Res Pract. 1998, 194: 815-819.